InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,259.75
(
-0.33%
)
US TECH 100
22,140.00
(
-0.35%
)
Dow Jones
44,371.51
(
-0.63%
)
Brent Oil
70.16
(
0.00%
)
Bitcoin
117,972.88
(
0.34%
)
Post# of 689182
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (4) Keep Next 10 Report Keyboard Shortcuts
Replies (4) Next 10 Prev Next

georgie18

Send PM Follow Ignore
Followers 2291
Posts 107201
Boards Moderated 3
Alias Born 12/17/2011

georgie18

Member Level

Re: georgie18 post# 673495

Monday, 06/16/2025 8:31:10 AM

Monday, June 16, 2025 8:31:10 AM

Post# of 689182
IMRX...$2.15...🥳... CAMBRIDGE, Mass., June 16, 2025 (GLOBE NEWSWIRE) -- Immuneering Corporation (Nasdaq: IMRX), a clinical-stage oncology company outpacing cancer to help patients outlive their disease, today announced that it will host a conference call and live webcast at 8:00 am ET on June 17, 2025. The company is excited to provide updates from its ongoing Phase 2a clinical trial of IMM-1-104 in first-line pancreatic cancer patients.

The conference call will be webcast live and archived in the Investor Relations section of Immuneering’s website at Events & Presentations | Immuneering Corporation.
Public Reply Private Reply New Post
Keep Last Read
Replies (4) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (4) Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up